BRCA mutation

BRCA Mutation

Introduction

A BRCA mutation refers to a mutation in either of the BRCA1 or BRCA2 genes, known for their role in suppressing tumors. Mutations in these genes can significantly increase an individual's risk of developing breast and ovarian cancer, leading to what is known as hereditary breast-ovarian cancer syndrome. While only 5-10% of breast cancer cases are attributed to these mutations, their impact on affected individuals is significant, with a markedly increased risk of cancer.

Structure of the BRCA1 and BRCA2 genes.

Genetic Background

The BRCA1 and BRCA2 genes are crucial for DNA repair, maintaining genomic stability, and preventing uncontrolled cell growth. Mutations in these genes can lead to the loss of tumor suppressor function, allowing for the development of cancerous cells.

Types of Mutations

Hundreds of mutations in the BRCA1 and BRCA2 genes have been identified, ranging from small deletions and insertions to large genomic rearrangements. Some mutations are known to be harmful and increase cancer risk, while others are considered variants of uncertain significance (VUS), with no proven impact on cancer risk.

Implications for Health

Women with harmful BRCA1 or BRCA2 mutations face a significantly increased risk of developing breast and ovarian cancer. Specifically, they have:

• A fivefold increased risk of breast cancer.
• A ten to thirtyfold increased risk of ovarian cancer.

Men with these mutations also face an increased risk of breast cancer and prostate cancer, though to a lesser degree than women.

Testing for BRCA Mutations

Genetic testing for BRCA1 and BRCA2 mutations can identify individuals at high risk for breast and ovarian cancer, enabling them to take preventive measures. Testing is recommended for individuals with a strong family history of these cancers or known mutations in the family.

A genetic testing kit for identifying BRCA mutations.

Management Strategies

Individuals with harmful BRCA mutations may consider various strategies to manage their cancer risk, including:

• Increased surveillance for breast and ovarian cancer.
• Prophylactic surgeries, such as mastectomy and oophorectomy, to remove at-risk tissues.
• Chemoprevention with medications like tamoxifen.

Ethical and Social Considerations

The decision to undergo genetic testing for BRCA mutations raises ethical and social considerations, including privacy concerns, the potential for genetic discrimination, and the psychological impact of knowing one's genetic risk for cancer.

See Also

• Hereditary breast-ovarian cancer syndrome
• Genetic testing
• Tumor suppressor gene
• Breast cancer
• Ovarian cancer

References

• "Genetics of Breast and Gynecologic Cancers." National Cancer Institute.
• "BRCA1 and BRCA2: Cancer Risk and Genetic Testing." National Institutes of Health.

External Links

• National Cancer Institute: BRCA Fact Sheet
• Genome.gov: BRCA1 and BRCA2

BRCA mutation Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski